Used filter(s): 70 items found

  • Remove all filters
  • Period: From: 2021-01-01
  • Document category:
    • Annual Report

AMADA Annual Report 2020 (Azerbaijan)

11 Oct 2021

AMADA Annual Report 2020 (Azerbaijan) / Azerbaijan National Anti-Doping Agency (AMADA). - Baku : AMADA, 2021

Sports Integrity Australia Annual Report 2020-2021

1 Oct 2021

Sports Integrity Australia Annual Report 2020-2021 / Sports Integrity Australia. - Canberra, 2021

Contents:

Chapter 1 - Ceo Message

Chapter 2 - Overview

Chapter 3 - Feature Articles

Chapter 4 - Key Projects

Chapter 5 - Advisory Council

Chapter 6 - Australian Sports Drug Medical Advisory Committee

Chapter 7 - Annual Performance Statement

Chapter 8 - Management And Accountability

Chapter 9 - Financial Statements

Chapter 10 - Appendixes, Abbreviations And Glossary

Chapter 11 - Indexes

NADA Austria Annual Report 2020

31 Mar 2021

Jaresbericht 2019 / Natonale Anti-Doping Agentur Austria (NADA Austria). - Wien : NADA Austria, 2020

Contents:

NADA Austria

  • Leitbild, Vision, Mission, Werte, Ziele, Qualitätsmanagement
  • Kommissionen
  • Mitarbeiterinnen und Mitarbeiter
  • Nationale und internationale Kooperationen

DopingkontrollSystem

  • Dopingkontrollprogramm 2020
  • Dopingkontrollstatistik 2020

Medizin

  • Medikamentenabfrage - MedApp
  • Medizinische Ausnahmegenehmigungen

Recht

  • Welt-Anti-Doping-Code
  • Anti-Doping Bundesgesetz 2021
  • "Operation Aderlass" (Update)
  • Verstöße gegen die Anti-Doping Bestimmungen 2020

Information & Prävention

  • International Standard for Education
  • Online
  • Social Media
  • Vorträge, Schulungen und Info-Tour
  • Schulungsprogramme
  • Kampagnen und Kooperationen

Ausblick NADA Austria
Anlagen

Dopingautoriteit Annual Report 2021 (Netherlands)

2 Aug 2022

Dopingautoriteit Annual Report 2021 (Netherlands) / Anti-doping Authority Netherlands (Dopingautoriteit). - Capelle aan den IJssel : Dopingautoriteit, 2022

Contents:

Chapter 1 – Education
Chapter 2 – Doping control
Chapter 3 – Intelligence & Investigations
Chapter 4 – Disciplinary Proceedings
Chapter 5 – Legal Affairs
Chapter 6 – Scientific research
Chapter 7 – Knowledge management
Chapter 8 – Therapeutic Use Exemptions
Chapter 9 – International Affairs
Chapter 10 – People & organisation
--------------------------
Annex 1 - Financial overview
Annex 2 - Members of Advisory Board and Committees
Annex 3 - Personnel
Annex 4 - Overview of presentations and scientific publications
Annex 5 - Secondary positions
Annex 6 – Abbreviations
Annex 7 – Result management

Dopingautoriteit Annual Report 2020 (Netherlands)

28 May 2021

Dopingautoriteit Annual Report 2020 (Netherlands) / Anti-doping Authority Netherlands (Dopingautoriteit). - Capelle aan den IJssel : Dopingautoriteit, 2021

Contents:

Chapter 1 – Education
Chapter 2 – Doping control
Chapter 3 – Intelligence & Investigations
Chapter 4 – Disciplinary Proceedings
Chapter 5 – Legal Affairs
Chapter 6 – Scientific research
Chapter 7 – Knowledge management
Chapter 8 – Therapeutic Use Exemptions
Chapter 9 – International Affairs
Chapter 10 – People & organisation
--------------------------
Annex 1 - Financial overview
Annex 2 - Members of Advisory Board and Committees
Annex 3 - Personnel
Annex 4 - Overview of presentations and scientific publications
Annex 5 - Secondary positions
Annex 6 – Abbreviations
Annex 7 – Result management

WADA - Compliance Annual Report 2020

11 Mar 2021

Compliance Annual Report 2020 / World Anti-Doping Agency (WADA). - Montreal : WADA, 2021



WADA has publishes its 2020 Code Compliance Annual Report (Report). This second yearly report of its kind is an important element of WADA’s commitment to transparency and of WADA’s Compliance Strategy that was endorsed by WADA’s Executive Committee in 2019.

One of WADA’s primary roles as the global regulatory body for anti-doping is to monitor effective implementation of the World Anti-Doping Code (Code) and its related International Standards (Standards) by over 350 Anti-Doping Organizations (ADOs); such as, National Anti-Doping Organizations (NADOs), International Federations (IFs) and Major Event Organizations.

In particular, the purpose of the Report is to:

  • Clearly outline the achievements and challenges of WADA’s Compliance Monitoring Program in an integrated fashion, measuring objectives against key performance indicators through quantitative and qualitative analysis, including areas for improvement;
     
  • Detail the interpretation and implications of the findings, trends and lessons learned over time towards Code Signatory Organizations, enhancing their compliance maturity as defined in the Compliance Strategy; and
     
  • Identify opportunities for continual improvement that are the foundation for the following year’s Compliance Annual Plan. This cycle is repeated annually as WADA seeks to develop compliance maturity through continual improvement of its own compliance activities and the global anti-doping system.

Some of the key findings of the Report include the following:

  • Flexible compliance measures applied by WADA to recognize the impact of the COVID-19 pandemic on Code Signatories, in particular the temporary freezing of deadlines and enforcement procedures in the compliance monitoring program, resulted in fewer corrective actions being implemented by Signatories.

  • The area of results management generated a significant number of non-conformities across WADA’s monitoring programs compared with previous years.
     
  • Due to the more complex nature of their anti-doping programs, NADOs generated more non-conformities than IFs and took longer to implement corrective actions.
     
  • Agencies and organizations such as the International Testing Agency (ITA) and the Canadian NADO, to which a number of IFs delegated some or all parts of their anti-doping program, contributed to significantly improve IF anti-doping program independence and compliance.
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin